Enter multiple symbols separated by commas

Search results for "CELL"



About 72 results. Sort By: Date | Relevance
How to charge your phone in the great outdoors

Innovative technology is helping bring camping and barbecuing into the 21st century. How?
Source: CNBC.com | By: Anmar Frangoul | Special to CNBC.com
Stock collapse coming?  

Bill Fleckenstein, Fleckenstein Capital President, discusses his short ideas and explains why he says the market and the Fed are "trapped."
Source: CNBC.com
CNBC update: Gawker gives out Trump's number  

James Holmes, the gunman in the Colorado massacre, could still face the death penalty; and the website Gawker has made Donald Trump's cell phone number public, reports CNBC's Sue Herera.
Source: CNBC.com
Two bulls on Disney  

David Miller, Topeka Capital Markets, has a buy rating on Disney looking forward to the Shanghai park and Star Wars; and Anthony DiClemente, Nomura Securities, also has a buy rating on the stock.
Source: CNBC.com
Allies on Wall Street have uneasy prison reunion

Two former friends from Wall Street now share an awkward relationship at a prison outside of Boston, reports the New York Times.
Source: The New York Times | By: Anita Raghavan
AT&T bundles TV, wireless  

AT&T is rolling out a new all-in-one TV and wireless phone bundle. CNBC's Jon Fortt, and Jon Steinberg, Daily Mail North America, provide perspective.
Source: CNBC.com
Firms offer 'dark social' to protect your privacy

Growing concerns over consumer data privacy online are leading to the rise of more "dark social" apps and ad-blocking services.
Source: CNBC.com | By: Michelle Castillo
Hot money out of Apple and China?  

Mad Money host Jim Cramer shares his take on the impact China is having on Apple.
Source: CNBC.com
FireEye CEO: Strong quarter overall  

Insight on the quarter and the departure of the company's CFO, with David DeWalt, FireEye chairman and CEO, and Mad Money host Jim Cramer.
Source: CNBC.com
UPDATE 1-Amgen profit tops Street view, boosts full-year forecast

July 30- Amgen Inc on Thursday reported higher-than-expected second-quarter profit and revenue, helped by strong sales of its Enbrel rheumatoid arthritis drug and cost cutting, and the company raised its full-year forecasts. Excluding special items, Amgen earned $2.57 per share, topping analysts' average expectations by 14 cents, according to Thomson...
Source: Reuters | By: Bill Berkrot